EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TNF-α and IL-8 Are Helpful in the Prediction of Late Post-COVID-19 Venous Thromboembolic Disease—Single-Center Prospective Study

Dorota Wyrostkiewicz iD, Katarzyna B Lewandowska iD, Ewa Jankowska, Małgorzata Dybowska, Małgorzata E Jędrych, Katarzyna Zimna iD, Adriana Roży, Monika Szturmowicz, Witold Tomkowski, Małgorzata Sobiecka iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27209281 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Dorota Wyrostkiewicz und 9 weiteren Autor:innen. Beteiligte Einrichtung: First Department of Lung Diseases, Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland. Hauptthemen laut MEDLINE: COVID-19, Interleukin-8, Venous Thromboembolism, Tumor Necrosis Factor-alpha. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Post-COVID-19 syndrome is associated with persistent inflammation and an elevated risk of late venous thromboembolism (VTE). The role of proinflammatory cytokines has been well documented in the acute phase of the disease, but their potential role in late post-COVID-19 VTE remains unknown. What is the prevalence of VTE among symptomatic post-COVID-19 patients, and which laboratory parameters could enhance the diagnostic accuracy for VTE in these patients? Consecutive patients with objectively confirmed previous SARS-CoV-2 infection, admitted to a single department of lung diseases in a tertiary hospital due to sustained symptoms of dyspnea and/or exercise intolerance, were included. Clinical assessment and laboratory testing, including cytokine profiling (Il-1β, IL-6, IL-8, IL-10, TNF-α), PAI-1, and ferritin, were performed. VTE events (pulmonary embolism and/or deep vein thrombosis) were confirmed by standard imaging. Clinical and laboratory parameters were compared between participants with and without VTE. 108 patients: 69 (63.9%) males and 39 (36.1%) females, entered the study. VTE episodes were diagnosed in 39.8% (16.7% in the course of COVID-19 and 23.1% after the acute phase of the disease). Patients who entered the study ≤6 months and >6 months from acute COVID-19 infection were compared. Median D-dimer concentration was higher in patients with VTE that occurred within 6 months from the COVID-19 diagnosis compared to the non-VTE group (607 ng/mL vs. 428 ng/mL, borderline significance, p = 0.0595). Median_IL-8 concentration was significantly higher in those who developed VTE more than 6 months after COVID-19 compared to non-VTE patients: 10.19 pg/mL vs. 6.61 pg/mL, respectively, p = 0.048. The same was noted for TNF-α (39.02 pg/mL vs. 24 pg/mL, respectively, p = 0.011). The best diagnostic utility for VTE prediction was obtained for TNF-α concentration in symptomatic patients diagnosed >6 months from acute COVID-19 infection (ROC AUC 0.73, 95% CI 0.57–0.91). TNF-α was an independent risk factor of VTE episodes in the whole study group. Detection of elevated IL-8 and TNF-α levels later than 6 months from acute COVID-19 disease may help to identify patients at increased risk of late venous thromboembolism; nevertheless, further studies are needed to validate this observation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Interleukin-8Venous ThromboembolismTumor Necrosis Factor-alphaHumansFemaleMaleProspective StudiesMiddle AgedSARS-CoV-2AgedPulmonary EmbolismPost-Acute COVID-19 SyndromeBiomarkersFibrin Fibrinogen Degradation Products

Stichwörter der Autor:innen

COVID-19D-dimerIL-8TNF-αcytokinespost-COVID syndromethromboembolismvenous thromboembolism

Substanzen

Interleukin-8Tumor Necrosis Factor-alphaBiomarkersFibrin Fibrinogen Degradation Productsfibrin fragment D

Autor:innen und Institutionen

  • First Department of Lung Diseases, Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland.
  • Department of Genetics, Institute of Tuberculosis and Lung Diseases, Płocka 26, 01-138 Warsaw, Poland.
  • TS Clinic, Górczewska 228 E, 01-460 Warsaw, Poland.

ORCID-Profile: Dorota Wyrostkiewicz, Katarzyna B Lewandowska, Katarzyna Zimna, Małgorzata Sobiecka

Zitieren

APA

Wyrostkiewicz, D., Lewandowska, K. B., Jankowska, E., Dybowska, M., Jędrych, M. E., Zimna, K., Roży, A., Szturmowicz, M., Tomkowski, W., & Sobiecka, M. (2026). TNF-α and IL-8 Are Helpful in the Prediction of Late Post-COVID-19 Venous Thromboembolic Disease—Single-Center Prospective Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209281

Vancouver

Wyrostkiewicz D, Lewandowska KB, Jankowska E, Dybowska M, Jędrych ME, Zimna K, et al. TNF-α and IL-8 Are Helpful in the Prediction of Late Post-COVID-19 Venous Thromboembolic Disease—Single-Center Prospective Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209281

BibTeX
@article{Wyrostkiewicz2026,
  author = {Wyrostkiewicz, Dorota and Lewandowska, Katarzyna B and Jankowska, Ewa and Dybowska, Małgorzata and Jędrych, Małgorzata E and Zimna, Katarzyna and Roży, Adriana and Szturmowicz, Monika and Tomkowski, Witold and Sobiecka, Małgorzata},
  title = {TNF-α and IL-8 Are Helpful in the Prediction of Late Post-COVID-19 Venous Thromboembolic Disease—Single-Center Prospective Study},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27209281}
}
Kostenlos starten →